Invention Grant
- Patent Title: Antibodies binding AXL
-
Application No.: US15938961Application Date: 2018-03-28
-
Publication No.: US10201607B2Publication Date: 2019-02-12
- Inventor: Esther Breij , David Satijn , Edward Norbert Van Den Brink , Dennis Verzijl , Rob N. De Jong , Paul Parren , Riemke Van Dijkhuizen Radersma
- Applicant: GENMAB A/S
- Applicant Address: DK Copenhagen V
- Assignee: GENMAB A/S
- Current Assignee: GENMAB A/S
- Current Assignee Address: DK Copenhagen V
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: DK201400380 20140711; DK201400489 20140901; DK201400746 20141222; DK201500283 20150512
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K47/68 ; C07K16/28 ; C07K16/30 ; A61K39/395
Abstract:
The present invention relates to anti-AXL antibodies, immunoconjugates, compositions and method of treatment of cancer with such anti-AXL antibodies, immunoconjugates, or compositions.
Public/Granted literature
- US20180214549A1 ANTIBODIES BINDING AXL Public/Granted day:2018-08-02
Information query
